Results 41 to 50 of about 451,742 (343)

Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats

open access: yesFrontiers in Physiology, 2019
Portal hypertension (PHT) resulting from splanchnic vasodilatation is a major cause of morbidity and mortality in patients with cirrhosis. The renin-angiotensin system (RAS) plays an important role in splanchnic vasodilatation in cirrhosis.
Lakmie S. Gunarathne   +3 more
doaj   +1 more source

Blood mobilization from the liver of the anaesthetized dog [PDF]

open access: yes, 1998
The abdominal circulation contains a high proportion of the total blood volume and this can change either passively in response to changes in vascular distending pressure or actively (termed a capacitance response) to changes in sympathetic nervous ...
Drinkhill, M.J.   +3 more
core   +1 more source

Pre-operative hepatic artery resistive index is a non-invasive predictive indicator of prognosis in biliary atresia

open access: yesJournal of Indian Association of Pediatric Surgeons, 2017
Aims: The aim of this study is to evaluate hepatic artery resistive index (HARI) as a noninvasive prognostic predictor by correlating it with peripheral blood nitric oxide (NO) levels, portal pressure (PP) and histopathological changes in the liver in ...
Deepak Mittal   +7 more
doaj   +1 more source

Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment

open access: yesEuropean Medical Journal, 2021
Non-alcoholic fatty liver disease (NAFLD) is one of the emerging global health problems due to an increase of burden worldwide. It has been known that NAFLD is strongly associated with metabolic syndrome.
Cosmas Rinaldi Adithya Lesmana   +4 more
doaj   +1 more source

Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure [PDF]

open access: yes, 2015
AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT).
Korshunov, Vyacheslav A.   +4 more
core   +1 more source

Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension [PDF]

open access: yes, 2014
Cirrhosis is the final stage of most of chronic liver diseases, and is almost invariably complicated by portal hypertension, which is the most important cause of morbidity and mortality in these patients. This review will focus on the non-invasive methods
Ashkenazi, Eyal   +4 more
core   +2 more sources

Effect of Pulse Shaping on Subharmonic Aided Pressure Estimation In Vitro and In Vivo. [PDF]

open access: yes, 2016
OBJECTIVES: Subharmonic imaging (SHI) is a technique that uses the nonlinear oscillations of microbubbles when exposed to ultrasound at high pressures transmitting at the fundamental frequency ie, f METHODS: Eight waveforms with different envelopes were ...
Dave, Jaydev K.   +11 more
core   +2 more sources

The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties [PDF]

open access: yes, 2017
In conclusion, prospective RCT would be needed on the use of NSBBs in decompensated cirrhotic patients with ascites however these trials are difficult to organize and will need a large sample size.
Di Gregorio, Vincenza   +3 more
core   +1 more source

National Consensus on Portal Hypertension Management in Indonesia

open access: yesActa Medica Indonesiana, 2022
Portal hypertension is a clinical syndrome that consists of hypersplenism, ascites, gastroesophageal varices, and encephalopathy. This condition is marked by increased portal pressure gradient and may occur with or without liver cirrhosis.
Juferdy Kurniawan   +7 more
doaj   +2 more sources

Therapeutic effect of captopril, pentoxifylline, and cordyceps sinensis in pre-hepatic portal hypertensive rats

open access: yesThe Saudi Journal of Gastroenterology, 2012
Background/Aim: Portal hypertension is an important and potentially fatal complication of liver disease whereby cellular and fibrotic alterations manifest to increase portal venous pressure. The aim of this study is to investigate the effect of captopril,
Ahmed F Ahmed   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy